🔎 Trials Near Me

Nyumbani › Colitis ya Ulcerative › Florida › Orlando

Majaribio ya kliniki ya Colitis ya Ulcerative katika Orlando, FL

Masomo 22 ya Colitis ya Ulcerative yanatafuta washiriki katika vituo vya Orlando na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

InaajiriHatua 2
  • Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
  • Clinical Research of Osceola /ID# 280593, Kissimmee · Mi 16 mbali
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

InaajiriHatua 4
  • Endoscopic Research, Inc., Orlando
  • Orlando Health-Orlando Regional Medical Center, Orlando
  • Digestive and Liver Center of Florida, P.A., Kissimmee · Mi 16 mbali
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328

Confirmatory Clinical Study in Active Ulcerative Colitis

InaajiriHatua 2
  • Orlando Gastroenterology, P.A., Orlando
Umri 16 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 2
  • Orlando Health Digestive Health Institute, Orlando
  • AdventHealth Orlando, Orlando
  • Novum Research, LLC, Clermont · Mi 24 mbali
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
  • Xencor Investigative Site, Kissimmee · Mi 16 mbali
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

InaajiriHatua 2
  • Site 007, Kissimmee · Mi 16 mbali
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 2
  • Site US-026, Orlando
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

InaajiriHatua 2
  • AdventHealth Orlando ( Site 1074), Orlando
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

InaajiriHatua 2
  • Clinical Research of Osceola, LLC, Kissimmee · Mi 16 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06979336

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

InaajiriHatua 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

InaajiriHatua 2
  • Digestive and Liver Center of Florida, Orlando
  • Clinical Research of Osceola, Kissimmee · Mi 16 mbali
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 2
  • AdventHealth Orlando, Orlando
  • Clinical Research of Osceola, Kissimmee · Mi 16 mbali
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

InaajiriHatua 4
  • Endoscopic Research Inc, Orlando
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 3
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee · Mi 16 mbali
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT07185009

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

InaajiriHatua 2
  • Primary Care of Osceola, Kissimmee · Mi 16 mbali
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 21 Ago 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 3
  • Orlando Health, Inc. - Site Number: 8400084, Orlando
  • AdventHealth Orlando - Site Number: 8400070, Orlando
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee · Mi 16 mbali
  • na zaidi ya 1
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Inaajiri
  • Advent Health, Orlando
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

InaajiriUtafiti wa uchunguzi
  • AdventHealth, Orlando
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

InaajiriUtafiti wa uchunguzi
  • Orlando Health/Digestive Health Institute, Orlando
  • Digestive and Liver Center of Florida Kissimmee, Kissimmee · Mi 16 mbali
Umri 18 hadi 64 · Jinsia zote · Imesasishwa 9 Jul 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

InaajiriHatua 2
  • Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
Umri 12 hadi 17 · Jinsia zote · Imesasishwa 8 Jul 2026 · NCT05287126

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

InaajiriHatua 2
  • Mirador Therapeutics Selected Site, Orlando
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 12 Mac 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Inaajiri
  • Orlando Health, Orlando
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 8 Jan 2026 · NCT05987852

Majaribio ya Colitis ya Ulcerative katika miji mingine

Masomo mengine katika Orlando

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.